関連する実験動画
Updated: Jul 10, 2026

11:00
Determination of the Gas-phase Acidities of Oligopeptides
Published on: June 24, 2013
ウレアス:クラスターモデルの量子化学計算
Dimas Suárez1, Natalia Díaz, Kenneth M Merz
1Departamento de Química Física y Analítica, Universidad de Oviedo, C/ Julián Clavería 8, 33006 Oviedo, Asturias, Spain.
Journal of the American Chemical Society
|December 11, 2003
まとめ
計算による研究により,ダイニッケル複合体は尿素酵素触媒の鍵となっていることが明らかになった. 発見は尿素水解機構に関する新しい洞察を提供し,水酸化物ブリッジと結合水分子の重要な役割を特定します.
科学分野:
- 計算化学はコンピュータ化学である.
- バイオケミストリー バイオケミストリー
- 酵素触媒は,酵素を触媒として用いる.
背景:
- 尿素酵素は尿素の水解を触媒化し,重要な生物学的プロセスである.
- 尿素酵素の活性部位を理解することは,その触媒機構の解明に不可欠です.
- ディニッケル複合体は,尿素酵素の活性部位のモデルとして提案されている.
研究 の 目的:
- 尿素酸で触媒化された尿素の水解に関連するダイニッケル複合体を計算的に調査する.
- ウレアースの構造,基板結合,および触媒機構の洞察を得るために.
- リアルな尿素酸活性部位モデルの電子および磁気特性を特徴付ける.
主な方法:
- 密度関数理論 (DFT) は,B3LYP関数を使用しています.
- 均衡の幾何学,電子特性,磁気特性,およびエネルギーの特徴.
- 尿素酵素活性部位を模倣した現実的なディニッケル複合体のモデリング.
主要な成果:
- 結晶学的尿酸塩基構造における水橋は,反鉄磁気結合と一致する水酸化物橋として識別されました.
- 好ましい触媒的方向性を有する単歯類と二歯類の尿素結合複合体を特徴付けました.
- 2つの異なる反応機構が調査され,橋渡し水酸化物とNi2結合水分子の役割が強調されました.
結論:
- この研究は,尿素酶触媒におけるディニッケル複合体の詳細な計算分析を提供します.
- この発見は,尿酸によって尿素の水解を制御する構造的および電子的要因を明確にします.
- 特定された反応機構は,酵素機能を理解し,触媒を設計するための貴重な洞察を提供します.
さらに関連する動画
関連する概念動画
Weak Acid Solutions
Few compounds act as strong acids. A far greater number of compounds behave as weak acids and only partially react with water, leaving a large majority of dissolved molecules in their original form and generating a relatively small amount of hydronium ions. Weak acids are commonly encountered in nature, being the substances partly responsible for the tangy taste of citrus fruits, the stinging sensation of insect bites, and the unpleasant smells associated with body odor. A familiar example of a...
Polyprotic Acids
Acids are classified by the number of protons per molecule that they can give up in a reaction. Acids such as HCl, HNO3, and HCN that contain one ionizable hydrogen atom in each molecule are called monoprotic acids. Their reactions with water are:
Calculating pH Changes in a Buffer Solution
A buffer can prevent a sudden drop or increase in the pH of a solution after the addition of a strong acid or base up to its buffering capacity; however, such addition of a strong acid or base does result in the slight pH change of the solution. The small pH change can be calculated by determining the resulting change in the concentration of buffer components, i.e., a weak acid and its conjugate base or vice versa. The concentrations obtained using these stoichiometric calculations can be used...
Titration Calculations: Strong Acid - Strong Base
Calculating pH for Titration Solutions: Strong Acid/Strong Base
A titration is carried out for 25.00 mL of 0.100 M HCl (strong acid) with 0.100 M of a strong base NaOH. The pH at different volumes of added base solution can be calculated as follows:
(a) Titrant volume = 0 mL. The solution pH is due to the acid ionization of HCl. Because this is a strong acid, the ionization is complete and the hydronium ion molarity is 0.100 M. The pH of the solution is then:
A titration is carried out for 25.00 mL of 0.100 M HCl (strong acid) with 0.100 M of a strong base NaOH. The pH at different volumes of added base solution can be calculated as follows:
(a) Titrant volume = 0 mL. The solution pH is due to the acid ionization of HCl. Because this is a strong acid, the ionization is complete and the hydronium ion molarity is 0.100 M. The pH of the solution is then:
Titration Calculations: Weak Acid - Strong Base
Calculating pH for Titration Solutions: Weak Acid/Strong Base
For the titration of 25.00 mL of 0.100 M CH3CO2H with 0.100 M NaOH, the reaction can be represented as:
For the titration of 25.00 mL of 0.100 M CH3CO2H with 0.100 M NaOH, the reaction can be represented as:
One-Compartment Open Model: Urinary Excretion Data and Determination of k
The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also be...

